Viatris (VTRS) Interest Coverage Ratio (2020 - 2026)
Viatris (VTRS) posted Interest Coverage Ratio of 0.05 for Q2 2026, up 107.87% on a QoQ basis from 0.66 in Q1 2026, and down 97.39% year-over-year from 2.0 in Q2 2025.
Analysis
Viatris (VTRS) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Viatris has reported Interest Coverage Ratio for 7 years, with the latest figure at 0.05 in Q2 2026.
- On a quarterly basis, Interest Coverage Ratio fell 97.39% year-over-year to 0.05 in Q2 2026; TTM through Jun 2026 was 0.18, a 96.52% increase from a year earlier, with the FY2025 full-year figure at 5.65, down 30870.27% from the prior year.
- Interest Coverage Ratio was 0.05 for Q2 2026 at Viatris, up from 0.66 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 4.84 in Q1 2022, with the low at 24.95 in Q1 2025.
- Average Interest Coverage Ratio over 5 years is 0.43, with a median of 1.48 recorded in 2024.
- The sharpest annual moves came in 2022 and 2025: Interest Coverage Ratio jumped 1414.7% in 2022, then slumped 1793.8% in 2025.
- Over 5 years, Interest Coverage Ratio stood at 1.37 in 2022, then sank by 135.72% to 3.23 in 2023, then surged by 53.63% to 1.5 in 2024, then fell by 7.71% to 1.61 in 2025, then surged by 103.24% to 0.05 in 2026.
- The last three Interest Coverage Ratio figures came in at 0.05 (Q2 2026), 0.66 (Q1 2026), and 1.61 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.53 Bn | 38.88 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.14 Bn | 18.25 Bn | 1.46 Bn | 0.05 |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | 3.02 |
| 4 | Amneal Pharmaceuticals | 5.45 Bn | 5.33 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.33 Bn | 492.63 Mn | 2.10 Bn | 1.87 |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn | -1.79 |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn | 5.97 |
| 9 | Fennec Pharmaceuticals | 400.20 Mn | 358.95 Mn | 17.15 Mn | 579.00 |
| 10 | RedHill Biopharma | 178.79 Mn | 178.79 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.05 |
| Mar 31, 2026 | -0.66 |
| Dec 31, 2025 | -1.61 |
| Sep 30, 2025 | 1.49 |
| Jun 30, 2025 | 2.00 |
| Mar 31, 2025 | -24.95 |
| Dec 31, 2024 | -1.50 |
| Sep 30, 2024 | 1.55 |
| Jun 30, 2024 | -1.65 |
| Mar 31, 2024 | 1.47 |
| Dec 31, 2023 | -3.23 |
| Sep 30, 2023 | 3.19 |
| Jun 30, 2023 | 2.57 |
| Mar 31, 2023 | 2.72 |
| Dec 31, 2022 | -1.37 |
| Sep 30, 2022 | 3.66 |
| Jun 30, 2022 | 3.76 |
| Mar 31, 2022 | 4.84 |
| Dec 31, 2021 | -0.52 |
| Sep 30, 2021 | 2.35 |